Canopy Growth Corporation

    CGC ·NASDAQ ·Medicinal Chemicals & Botanical Products ·Inc. in Z4
    Loading chart...
    Track markets on TradingView

    Loading financial statements...

    Financial statements

    data from SEC XBRL filings. Values are as-reported; restatements supersede originals. Values reported in .

    showing loading…

    Loading holders...

    Held by

    holders ( registered funds via N-PORT, institutional investors via 13F). Showing top by dollar value.

    Holder Type ETF MF Position ($) % of holder Δ % of holder Holder AUM

    Recent insider activity

    Last 90 days. Open-market trades (purchases & sales) by directors, officers, and 10%+ owners. 7 transactions across 6 insiders. Net: -84,822 shares, -$87,156.

    Date Insider Role Action Shares Price Value
    2026-09-28 BAYERN JOSEPH Director Sell -3,096 $0.93 -$2,869
    2026-09-28 Lazzarato David Angelo Director Sell -22,380 $0.93 -$20,742
    2026-09-28 Yanofsky Theresa Director Sell -14,920 $0.93 -$13,828
    2026-09-28 ATKINS M SHAN Director Sell -3,096 $0.93 -$2,869
    2026-09-17 Stewart Thomas Carlton See Remarks Sell -25,755 $0.93 -$23,952
    2026-08-24 Gedeon Christelle See Remarks Sell -13,344 $1.47 -$19,616
    2026-08-24 Stewart Thomas Carlton See Remarks Sell -2,231 $1.47 -$3,280

    Source: SEC Form 4 filings.

    Next expected filings

    • ~2026-11-06 10-Q expected by 2026-11-07 (in 21 days)
    • ~2027-02-05 10-Q expected by 2027-02-06 (in 112 days)
    • ~2027-06-15 10-K expected by 2027-06-28 (in 242 days)
    • ~2027-08-06 10-Q expected by 2027-08-07 (in 294 days)

    Predicted from historical filing cadence; not an SEC commitment.

    Recent SEC filings

    • 2026-10-16 8-K Delisting Notice
    • 2026-08-07 10-Q Quarterly Report
    • 2026-08-07 8-K Earnings Release; Financial Statements and Exhibits
    • 2026-08-07 8-K Changes in Auditor; Financial Statements and Exhibits
    • 2026-08-07 DEF 14A Proxy Statement
    • 2026-07-17 PRE 14A Preliminary Proxy Statement
    • 2026-06-15 10-K Annual Report
    • 2026-06-15 8-K Earnings Release; Financial Statements and Exhibits
    • 2026-05-15 8-K Financial Statements No Longer Reliable; Regulation FD Disclosure; Financial Statements and Exhibits
    • 2026-03-16 8-K Regulation FD Disclosure; Other Events; Financial Statements and Exhibits
    • 2026-02-06 10-Q Quarterly Report
    • 2026-02-06 S-3 Registration Statement
    • 2026-02-06 8-K Earnings Release; Financial Statements and Exhibits
    • 2026-01-09 S-3 Registration Statement
    • 2026-01-08 8-K Material Agreement Entered; Material Financial Obligation; Unregistered Equity Sale; Regulation FD Disclosure; Other Events; Financial Statements and Exhibits